The FITC represents oncologists and research scientists involved in understanding tumor immunity and developing cancer immunotherapies in collaboration with French academic societies (SFI, SFC, LySA etc.).
Our objective is to bridge national institutions (HAS, CEPS, INCa, etc. ) and governing bodies (Senate, National assembly) in order to improve the implementation of immunotherapies in France and to increase funding of research in cancer immunology.
For complete transparency in access to immunotherapy, you will discover soon the list of cancers for which treatment by immunotherapy is covered by social healthcare in France.
Discover soon the list of clinical trials in cancer immunotherapy currently open in France.